Literature DB >> 17939682

Design, synthesis, and evaluation of linear and cyclic peptide ligands for PDZ10 of the multi-PDZ domain protein MUPP1.

Sudhir C Sharma1, Chamila N Rupasinghe, Rachel B Parisien, Mark R Spaller.   

Abstract

PDZ10 is the 10th of 13 PDZ domains found within MUPP1, a cytoplasmic scaffolding protein first identified as an endogenous binding partner of serotonin receptor type 2c (5HT2c). This association, as with those of several other interacting proteins that have subsequently been identified, is mediated through the C-terminal tail of the PDZ domain partner. Using isothermal titration calorimetry (ITC), we measured the thermodynamic binding parameters [changes in Gibbs free energy (DeltaG), enthalpy (DeltaH) and entropy (TDeltaS)] of the isolated PDZ10 domain for variable-length N-acetylated peptides from the 5HT2c serotonin receptor C-terminal sequence, as well as for octapeptides of eight other putative partner proteins of PDZ10 (5HT2a, hc-kit, hTapp1, mTapp2, TARP, NG2, claudin-1, and HPV-18 E6). In length dependence studies of the 5HT2c sequence, the maximal affinity of the peptides leveled off rapidly and further elongation did not significantly improve the dissociation constant (Kd) of 11 microM observed with the pentapeptide. Among the native partners of PDZ10, octapeptides derived from the hc-kit and 5HT2c proteins were the strongest binders, with Kd values of 5.2 and 8.5 microM, respectively. The heat capacity change (DeltaCp) for the 5HT2c octapeptide was determined to be -94 cal/mol, and a calculated estimate indicates burial of polar and apolar surface areas in equal measure upon ligand binding. Peptides with phosphoserine at either the P-1 or P-2 position experienced decreased affinity, which is in accord with the hypothesis that reversible phosphorylation is a possible mechanism for regulating PDZ domain-mediated interactions. Additionally, two conformationally constrained side chain-bridged cyclic peptide ligands were also designed, prepared, evaluated by ITC, and shown to bind PDZ10 primarily through a favorable change in entropy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939682     DOI: 10.1021/bi7008135

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Therapeutic use of PDZ protein-protein interaction antagonism.

Authors:  Nick X Wang; Ho-Jin Lee; Jie J Zheng
Journal:  Drug News Perspect       Date:  2008-04

Review 2.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

Review 3.  Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.

Authors:  Kelly A Berg; William P Clarke; Kathryn A Cunningham; Umberto Spampinato
Journal:  Neuropharmacology       Date:  2008-06-17       Impact factor: 5.250

4.  The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.

Authors:  Patrick R Cushing; Abigail Fellows; Daniel Villone; Prisca Boisguérin; Dean R Madden
Journal:  Biochemistry       Date:  2008-08-29       Impact factor: 3.162

5.  Simultaneous prediction of binding free energy and specificity for PDZ domain-peptide interactions.

Authors:  Joseph J Crivelli; Gordon Lemmon; Kristian W Kaufmann; Jens Meiler
Journal:  J Comput Aided Mol Des       Date:  2013-12-05       Impact factor: 3.686

Review 6.  Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and intervention.

Authors:  Wei-Chun Jim Hsu; Carol Lynn Nilsson; Fernanda Laezza
Journal:  Front Psychiatry       Date:  2014-08-21       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.